Jones Ventures INTL Acquisition1
JONER · NASDAQ
About JONER
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Jul 14, 2026
- Sector
- N/A
- Industry
- N/A
JONER key statistics
- Market cap
- 281.62M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 2.41K
- Volume
- 10.46K
- Open price
- $0.14
- High today
- $0.14
- Low today
- $0.14
- 52 Week high
- $0.20
- 52 Week low
- $0.1001
Jones Ventures INTL Acquisition1 (JONER) at a glance
As of Oct 27, 2026, Jones Ventures INTL Acquisition1 (JONER) shares are priced at $0.14, giving the company a market cap of 281.62M and a price-to-earnings ratio of 0.00.
Volume so far is 10.46K shares, above the average of 2.41K shares a day.
Over the past year Jones Ventures INTL Acquisition1 has ranged from $0.1001 to $0.20, and now sits 40% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- RDARRaadr$0.0002−16.67%
- AXGSolowin Holdings$0.04−25.65%
- AEFIAmerican EcoFuels$0.0009+12.50%
- SHFSSHF Holdings$0.1158+23.19%
- DVLTDatavault AI$0.067−49.55%
- MASNMaison Luxe$0.0002+0.00%
- XXII22nd Century Group$0.1048+18.55%
- NBNDNetBrands$0.0007+0.00%
- NEXRNexera Technologies$0.5454+21.77%
- TIPSTianrong Internet Products & Services$0.0011+57.14%
- AITXArtificial Intelligence Technology Solutions$0.0008−20.00%
Newly listed
Companies that went public in the past six weeks
- LYCALycia Therapeutics$26.11−9.50%
- DAVIDAVION HEALTHCARE$3.00−26.29%
- TCXBTCGX Acquisition Corp. II$10.28+0.10%
- CTYCITY THERAPEUTICS$20.86+0.34%
- IAMIambic Therapeutics$14.00−2.85%
- AMROAmaero$6.04+12.48%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$13.79−0.58%
- RTSNRetension Pharmaceuticals$13.52−5.06%
- PAXGUPine Tree Acquisition$10.00−0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.20+1.36%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.